| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Testis | 5 | 2025 | 405 | 1.570 |
Why?
|
| Cryptorchidism | 3 | 2022 | 37 | 1.220 |
Why?
|
| E2F1 Transcription Factor | 2 | 2021 | 47 | 1.180 |
Why?
|
| Urogenital Abnormalities | 4 | 2025 | 168 | 1.080 |
Why?
|
| Hypospadias | 4 | 2022 | 81 | 1.060 |
Why?
|
| Fertility | 4 | 2022 | 263 | 1.020 |
Why?
|
| Wnt4 Protein | 3 | 2022 | 20 | 0.970 |
Why?
|
| Sperm Tail | 1 | 2021 | 8 | 0.760 |
Why?
|
| Infertility | 1 | 2022 | 90 | 0.750 |
Why?
|
| Serine Proteases | 1 | 2021 | 7 | 0.750 |
Why?
|
| Spermatogenesis | 2 | 2021 | 166 | 0.700 |
Why?
|
| DNA | 5 | 2009 | 1592 | 0.670 |
Why?
|
| Prenatal Diagnosis | 3 | 2009 | 587 | 0.660 |
Why?
|
| Parovarian Cyst | 1 | 2017 | 11 | 0.570 |
Why?
|
| Hyperandrogenism | 1 | 2017 | 19 | 0.560 |
Why?
|
| Chromosomes, Human, Y | 2 | 2014 | 46 | 0.550 |
Why?
|
| Wnt Proteins | 2 | 2017 | 198 | 0.540 |
Why?
|
| Placenta | 3 | 2009 | 492 | 0.500 |
Why?
|
| Ovary | 7 | 2019 | 389 | 0.470 |
Why?
|
| Otx Transcription Factors | 1 | 2014 | 20 | 0.470 |
Why?
|
| Azoospermia | 1 | 2014 | 39 | 0.460 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2014 | 119 | 0.450 |
Why?
|
| Sequence Deletion | 2 | 2022 | 527 | 0.440 |
Why?
|
| Integrases | 3 | 2019 | 161 | 0.440 |
Why?
|
| Homeodomain Proteins | 2 | 2014 | 543 | 0.440 |
Why?
|
| Pituitary Gland | 2 | 2019 | 84 | 0.420 |
Why?
|
| Receptors, Androgen | 3 | 2025 | 409 | 0.420 |
Why?
|
| Haploinsufficiency | 1 | 2014 | 247 | 0.410 |
Why?
|
| Mice | 22 | 2025 | 17487 | 0.400 |
Why?
|
| Follistatin | 4 | 2004 | 35 | 0.400 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 2047 | 0.390 |
Why?
|
| Granulosa Cells | 5 | 2008 | 133 | 0.380 |
Why?
|
| Mice, Knockout | 10 | 2025 | 3715 | 0.370 |
Why?
|
| Infertility, Male | 2 | 2011 | 262 | 0.370 |
Why?
|
| Pseudogenes | 1 | 2011 | 52 | 0.370 |
Why?
|
| Nucleic Acid Amplification Techniques | 2 | 2009 | 65 | 0.350 |
Why?
|
| Pregnancy | 10 | 2019 | 7137 | 0.350 |
Why?
|
| Transcription Factors | 1 | 2020 | 2585 | 0.350 |
Why?
|
| Pregnancy Trimester, First | 2 | 2007 | 111 | 0.340 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 699 | 0.330 |
Why?
|
| Male | 25 | 2025 | 60040 | 0.310 |
Why?
|
| Animals | 23 | 2025 | 33728 | 0.310 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2019 | 226 | 0.300 |
Why?
|
| Chromosome Aberrations | 1 | 2011 | 614 | 0.300 |
Why?
|
| Genome, Human | 1 | 2014 | 1266 | 0.290 |
Why?
|
| Globins | 1 | 2007 | 35 | 0.290 |
Why?
|
| Maternal Exposure | 2 | 2019 | 148 | 0.290 |
Why?
|
| Obesity | 2 | 2017 | 2227 | 0.290 |
Why?
|
| Air Pollutants | 2 | 2019 | 101 | 0.290 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2025 | 353 | 0.280 |
Why?
|
| Microspheres | 1 | 2006 | 70 | 0.270 |
Why?
|
| Fetal Blood | 1 | 2007 | 177 | 0.270 |
Why?
|
| Adrenal Glands | 1 | 2006 | 41 | 0.260 |
Why?
|
| Genetic Techniques | 1 | 2006 | 107 | 0.260 |
Why?
|
| Inhibins | 1 | 2006 | 87 | 0.260 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 2585 | 0.250 |
Why?
|
| Cullin Proteins | 1 | 2025 | 14 | 0.250 |
Why?
|
| HEK293 Cells | 3 | 2025 | 740 | 0.250 |
Why?
|
| Reproduction | 2 | 2019 | 243 | 0.250 |
Why?
|
| Androgens | 2 | 2024 | 256 | 0.240 |
Why?
|
| Down Syndrome | 1 | 2007 | 195 | 0.240 |
Why?
|
| Spermatozoa | 3 | 2021 | 231 | 0.230 |
Why?
|
| Gene Targeting | 1 | 2005 | 179 | 0.230 |
Why?
|
| Ubiquitination | 1 | 2025 | 172 | 0.230 |
Why?
|
| RNA, Messenger | 4 | 2008 | 2817 | 0.230 |
Why?
|
| Viral Proteins | 1 | 2006 | 348 | 0.230 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 3083 | 0.230 |
Why?
|
| Female | 25 | 2022 | 65444 | 0.220 |
Why?
|
| Humans | 26 | 2025 | 123170 | 0.220 |
Why?
|
| RNA | 2 | 2006 | 574 | 0.220 |
Why?
|
| Infertility, Female | 2 | 2008 | 165 | 0.220 |
Why?
|
| Gubernaculum | 1 | 2022 | 1 | 0.210 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2022 | 28 | 0.210 |
Why?
|
| Spermatogonia | 1 | 2022 | 29 | 0.210 |
Why?
|
| HeLa Cells | 2 | 2024 | 809 | 0.200 |
Why?
|
| Cell Cycle | 2 | 2021 | 612 | 0.200 |
Why?
|
| Signal Transduction | 9 | 2021 | 4497 | 0.200 |
Why?
|
| Asthenozoospermia | 1 | 2021 | 6 | 0.190 |
Why?
|
| Heterochromatin | 1 | 2021 | 48 | 0.190 |
Why?
|
| Sperm Head | 1 | 2021 | 9 | 0.190 |
Why?
|
| Microtubule Proteins | 1 | 2021 | 27 | 0.190 |
Why?
|
| Blood-Testis Barrier | 1 | 2021 | 11 | 0.190 |
Why?
|
| I-kappa B Kinase | 1 | 2021 | 60 | 0.190 |
Why?
|
| Genetic Variation | 2 | 2020 | 1480 | 0.180 |
Why?
|
| Mice, Mutant Strains | 1 | 2021 | 382 | 0.180 |
Why?
|
| Texas | 3 | 2019 | 3547 | 0.170 |
Why?
|
| Pre-Eclampsia | 3 | 2018 | 223 | 0.170 |
Why?
|
| Chromosome Deletion | 2 | 2014 | 638 | 0.170 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2019 | 22 | 0.170 |
Why?
|
| Patched-1 Receptor | 1 | 2019 | 33 | 0.170 |
Why?
|
| Urogenital System | 1 | 2019 | 34 | 0.160 |
Why?
|
| Cell-Derived Microparticles | 2 | 2009 | 31 | 0.160 |
Why?
|
| Metals, Heavy | 1 | 2019 | 18 | 0.160 |
Why?
|
| Air Pollution, Indoor | 1 | 2019 | 30 | 0.160 |
Why?
|
| Odds Ratio | 2 | 2019 | 1243 | 0.160 |
Why?
|
| Child Health | 1 | 2019 | 53 | 0.160 |
Why?
|
| Pediatricians | 1 | 2019 | 65 | 0.150 |
Why?
|
| Case-Control Studies | 2 | 2019 | 3251 | 0.150 |
Why?
|
| Physical Examination | 1 | 2019 | 164 | 0.150 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 2 | 2008 | 26 | 0.150 |
Why?
|
| Models, Biological | 3 | 2021 | 1442 | 0.150 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2018 | 79 | 0.150 |
Why?
|
| DNA Copy Number Variations | 2 | 2014 | 939 | 0.140 |
Why?
|
| Hirsutism | 1 | 2017 | 19 | 0.140 |
Why?
|
| Sperm Capacitation | 3 | 2004 | 21 | 0.140 |
Why?
|
| Histones | 1 | 2021 | 527 | 0.140 |
Why?
|
| Menarche | 1 | 2017 | 33 | 0.140 |
Why?
|
| Animals, Newborn | 1 | 2021 | 991 | 0.140 |
Why?
|
| Nephrectomy | 1 | 2018 | 172 | 0.140 |
Why?
|
| Ureter | 1 | 2018 | 96 | 0.140 |
Why?
|
| Risk Factors | 4 | 2019 | 10010 | 0.130 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2533 | 0.130 |
Why?
|
| Wnt Signaling Pathway | 1 | 2017 | 195 | 0.130 |
Why?
|
| Hypogonadism | 1 | 2019 | 249 | 0.130 |
Why?
|
| Hospitals, Pediatric | 2 | 2019 | 780 | 0.130 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2004 | 124 | 0.130 |
Why?
|
| Adolescent | 6 | 2019 | 19095 | 0.120 |
Why?
|
| Dental Enamel | 2 | 2004 | 17 | 0.120 |
Why?
|
| Genitalia | 1 | 2014 | 36 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2008 | 459 | 0.120 |
Why?
|
| Adult | 6 | 2019 | 29034 | 0.120 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 639 | 0.110 |
Why?
|
| Logistic Models | 1 | 2019 | 1796 | 0.110 |
Why?
|
| Aging | 1 | 2021 | 1172 | 0.110 |
Why?
|
| Species Specificity | 1 | 2014 | 549 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 4346 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2014 | 242 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2018 | 628 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2014 | 609 | 0.100 |
Why?
|
| Cohort Studies | 2 | 2019 | 4704 | 0.090 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2011 | 9 | 0.090 |
Why?
|
| Short Stature Homeobox Protein | 1 | 2011 | 11 | 0.090 |
Why?
|
| Trophoblasts | 2 | 2009 | 112 | 0.090 |
Why?
|
| Sex Chromosome Aberrations | 1 | 2011 | 56 | 0.090 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2010 | 83 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 4 | 2005 | 456 | 0.090 |
Why?
|
| Hypertension | 1 | 2018 | 1284 | 0.090 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2009 | 44 | 0.080 |
Why?
|
| Body Height | 1 | 2011 | 210 | 0.080 |
Why?
|
| Pregnancy Trimesters | 1 | 2009 | 33 | 0.080 |
Why?
|
| Cell Line | 4 | 2009 | 2775 | 0.080 |
Why?
|
| Child | 4 | 2019 | 24225 | 0.080 |
Why?
|
| Mice, Transgenic | 2 | 2006 | 2390 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2011 | 757 | 0.080 |
Why?
|
| Growth Differentiation Factor 3 | 1 | 2008 | 3 | 0.080 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2008 | 23 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 574 | 0.080 |
Why?
|
| Nucleic Acids | 1 | 2008 | 23 | 0.080 |
Why?
|
| Smad2 Protein | 1 | 2008 | 49 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2008 | 54 | 0.080 |
Why?
|
| RNA Stability | 1 | 2008 | 85 | 0.080 |
Why?
|
| Adipose Tissue, White | 1 | 2008 | 79 | 0.080 |
Why?
|
| Prevalence | 1 | 2014 | 2405 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2024 | 1915 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2766 | 0.070 |
Why?
|
| Inhibin-beta Subunits | 1 | 2007 | 18 | 0.070 |
Why?
|
| Apoptosis | 3 | 2009 | 1781 | 0.070 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2006 | 2 | 0.070 |
Why?
|
| Infant | 3 | 2019 | 12339 | 0.070 |
Why?
|
| Ferrosoferric Oxide | 1 | 2006 | 26 | 0.070 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3011 | 0.070 |
Why?
|
| Prospective Studies | 1 | 2017 | 6028 | 0.070 |
Why?
|
| Leydig Cells | 1 | 2006 | 20 | 0.070 |
Why?
|
| Pregnancy Trimester, Second | 1 | 2006 | 158 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2019 | 13880 | 0.070 |
Why?
|
| Sertoli Cells | 1 | 2006 | 75 | 0.060 |
Why?
|
| Fertilization in Vitro | 2 | 2004 | 188 | 0.060 |
Why?
|
| Ameloblasts | 1 | 2004 | 5 | 0.060 |
Why?
|
| Incisor | 1 | 2004 | 7 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 1585 | 0.060 |
Why?
|
| Activins | 1 | 2004 | 74 | 0.060 |
Why?
|
| Calreticulin | 1 | 2004 | 19 | 0.060 |
Why?
|
| Potassium Channels | 1 | 2025 | 157 | 0.060 |
Why?
|
| Organogenesis | 1 | 2004 | 77 | 0.060 |
Why?
|
| Epithelium | 1 | 2004 | 366 | 0.050 |
Why?
|
| Genetic Testing | 1 | 2009 | 997 | 0.050 |
Why?
|
| Ubiquitins | 1 | 2022 | 42 | 0.050 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2022 | 28 | 0.050 |
Why?
|
| Gene Deletion | 1 | 2006 | 793 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 281 | 0.050 |
Why?
|
| Mutation | 2 | 2014 | 5773 | 0.050 |
Why?
|
| Oocytes | 1 | 2004 | 290 | 0.050 |
Why?
|
| Energy Metabolism | 2 | 2022 | 765 | 0.050 |
Why?
|
| Glucose | 2 | 2004 | 865 | 0.050 |
Why?
|
| Potassium | 1 | 2022 | 278 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2022 | 441 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 550 | 0.050 |
Why?
|
| Protein Binding | 1 | 2025 | 1743 | 0.050 |
Why?
|
| Homozygote | 1 | 2022 | 533 | 0.050 |
Why?
|
| Pituitary Gland, Anterior | 1 | 2019 | 21 | 0.040 |
Why?
|
| Seminal Vesicles | 1 | 2019 | 52 | 0.040 |
Why?
|
| In Situ Hybridization | 3 | 2004 | 473 | 0.040 |
Why?
|
| Sexual Maturation | 1 | 2019 | 48 | 0.040 |
Why?
|
| Cyclodextrins | 1 | 1999 | 4 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2019 | 37 | 0.040 |
Why?
|
| beta-Cyclodextrins | 1 | 1999 | 12 | 0.040 |
Why?
|
| Epididymis | 1 | 2019 | 54 | 0.040 |
Why?
|
| Hazardous Substances | 1 | 2019 | 17 | 0.040 |
Why?
|
| Cell Movement | 1 | 2022 | 831 | 0.040 |
Why?
|
| Maternal Inheritance | 1 | 2018 | 13 | 0.040 |
Why?
|
| Dextrans | 1 | 2018 | 46 | 0.040 |
Why?
|
| Documentation | 1 | 2019 | 115 | 0.040 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 58 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2019 | 234 | 0.040 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1999 | 213 | 0.040 |
Why?
|
| Hyaluronic Acid | 1 | 2018 | 96 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2018 | 151 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2019 | 15998 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2022 | 1265 | 0.030 |
Why?
|
| Cholesterol | 1 | 1999 | 525 | 0.030 |
Why?
|
| Ovulation | 2 | 2008 | 113 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2004 | 1682 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 594 | 0.030 |
Why?
|
| Testosterone | 1 | 2019 | 462 | 0.030 |
Why?
|
| Sperm-Ovum Interactions | 2 | 2004 | 24 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1170 | 0.030 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2019 | 710 | 0.030 |
Why?
|
| Gene Expression | 2 | 2008 | 1569 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 1012 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 3049 | 0.020 |
Why?
|
| Middle Aged | 1 | 2011 | 25966 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 8865 | 0.020 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2010 | 78 | 0.020 |
Why?
|
| HLA-G Antigens | 1 | 2009 | 13 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 96 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2009 | 93 | 0.020 |
Why?
|
| Cyclic AMP | 2 | 2000 | 247 | 0.020 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 96 | 0.020 |
Why?
|
| Membrane Lipids | 1 | 2008 | 33 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2008 | 56 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2009 | 223 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2008 | 94 | 0.020 |
Why?
|
| Cumulus Cells | 1 | 2008 | 43 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2008 | 93 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2004 | 3048 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2009 | 243 | 0.020 |
Why?
|
| Transcription Factor TFIID | 1 | 2007 | 13 | 0.020 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2007 | 14 | 0.020 |
Why?
|
| Corpus Luteum | 1 | 2007 | 25 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 260 | 0.020 |
Why?
|
| Adiposity | 1 | 2008 | 191 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 803 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2008 | 296 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2000 | 1611 | 0.020 |
Why?
|
| Keratin-14 | 1 | 2004 | 8 | 0.020 |
Why?
|
| Molar | 1 | 2004 | 3 | 0.010 |
Why?
|
| Keratins | 1 | 2004 | 56 | 0.010 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2004 | 9 | 0.010 |
Why?
|
| Body Patterning | 1 | 2004 | 122 | 0.010 |
Why?
|
| Zona Pellucida | 1 | 2004 | 12 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 15 | 1 | 2004 | 43 | 0.010 |
Why?
|
| Growth Differentiation Factor 9 | 1 | 2004 | 47 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 258 | 0.010 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2004 | 84 | 0.010 |
Why?
|
| United States | 1 | 2019 | 10629 | 0.010 |
Why?
|
| Dinoprostone | 1 | 2004 | 76 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2004 | 310 | 0.010 |
Why?
|
| Morphogenesis | 1 | 2004 | 212 | 0.010 |
Why?
|
| Germ Cells | 1 | 2004 | 192 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 370 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 533 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2018 | 12116 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 6204 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 341 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2004 | 452 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2007 | 1019 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 867 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1293 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2000 | 58 | 0.010 |
Why?
|
| Hexokinase | 1 | 2000 | 20 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1683 | 0.010 |
Why?
|
| Pyruvic Acid | 1 | 2000 | 35 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2004 | 1338 | 0.010 |
Why?
|
| Tyrosine | 1 | 2000 | 152 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1390 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 312 | 0.010 |
Why?
|
| Glycolysis | 1 | 2000 | 141 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2000 | 140 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2000 | 286 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2000 | 409 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 997 | 0.010 |
Why?
|
| 2-Hydroxypropyl-beta-cyclodextrin | 1 | 1999 | 4 | 0.010 |
Why?
|
| Cholesterol Esters | 1 | 1999 | 13 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 1095 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1999 | 108 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 1313 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 1283 | 0.010 |
Why?
|
| Cattle | 1 | 1999 | 559 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2004 | 2307 | 0.010 |
Why?
|